期刊文献+

结核药联合利福喷丁对肺结核患者免疫功能、炎症因子、VEGF及MMP-9的影响 被引量:29

Effects of Tuberculosis Drugs Combined with Rifapentine on the Immune Function, Inflammatory Factors, VEGF and MMP- 9 of TB Patients
暂未订购
导出
摘要 目的探讨结核药联合利福喷丁对肺结核患者免疫功能、炎症因子、VEGF及MMP-9的影响.方法60例肺结核患者按照随机分组法分为对照组(n=30)和观察组(n=30).对照组采用利福喷丁治疗,观察组在对照组基础上结合结核丸治疗.对比分析2组治疗前和治疗6个月后免疫功能、炎症因子、VEGF及MMP-9水平变化.结果治疗后,2组组CD3+、CD4+、CD4/CD8均较治疗前显著增加(P<0.05);治疗后,观察组CD3+、CD4+、CD4/CD8明显高于对照组(P<0.05);与治疗前相比,2组治疗后INF-γ水平均明显增加(P<0.05),IL-4、CRP、TNF-α水平明显降低(P<0.05);与对照组治疗后相比,观察组INF-γ水平明显较高(P<0.05),而IL-4、CRP、TNF-α水平较低(P<0.05);与治疗前相比,2组治疗后血清MMP-9、VEGF水平明显降低(P<0.05);与对照组治疗后相比,观察组血清MMP-9、VEGF水平明显降低(P<0.05).结论结核药联合利福喷丁可明显改善患者免疫功能、降低炎症反应、降低VEGF及MMP-9水平,从而有效控制病情,具有重要研究意义,值得进一步推广应用. Objective To investigate the effects of TB drugs combined with rifapentine on the immune function, inflammatory factors, VEGF and MMP- 9 of patients with pulmonary tuberculosis. Methods Sixty cases of tuberculosis patients were randomly divided into control group( n = 30) and observation group( n = 30). The control group was given rifapentine, while the treatment group was given tuberculosis pill treatment based on rifapentine. The immune function, inflammatory factors, VEGF and MMP- 9 levels of patients before and six months after treatment between the two groups. Results After treatment, the levels of CD3+, CD4+ and CD4/CD8 of patients in the two groups were increased significantly( P〈0.05). After treatment, the levels of CD3+, CD4+ and CD4/CD8 of patients in the observation group were significantly higher than those in the control group( P〈0.05). Compared with before treatment, after treatment INF- γ levels were significantly increased( P〈0.05), IL- 4, CRP, TNF- α levels were significantly lower( P〈0.05). Compared to the control groupafter treatment and observation Group INF- γ levels were significantly higher( P〈0.05), while IL- 4, CRP,TNF- α levels lower( P〈0.05). Compared with before treatment, the serum MMP- 9, VEGF levels were significantly lower after treatment( P〈0.05). Compared with the control group, the serum MMP- 9, VEGF levels of patients in the observation group were significantly lower after treatment( P〈0.05). Conclusions Tuberculosis drug combined with rifapentine can significantly improve the immune function of TB patients, reduce inflammation, reduce VEGF and MMP- 9 levels, so as to effectively control the disease, has important significance, and is worthy of further application.
作者 洪旭华 陈凯
出处 《昆明医科大学学报》 CAS 2016年第2期111-114,共4页 Journal of Kunming Medical University
基金 广东省医学科研基金资助项目(A2012438)
关键词 结核药 利福喷丁 肺结核 免疫功能 炎症因子 VEGF和MMP-9 Tuberculosis drug Rifapentine Tuberculosis Immune function Inflammatory factor VEGF and MMP-9
  • 相关文献

参考文献10

二级参考文献68

  • 1张学群,王洪霞,覃茂玉.利福喷丁治疗肺结核的疗效观察[J].临床肺科杂志,2005,10(1):54-55. 被引量:13
  • 2蒋锦琴,黄卫平,张小贤,周海鸥,严杰.中药结核丸对结核分枝杆菌体内外抗菌效果的观察[J].江西医学检验,2005,23(6):521-522. 被引量:20
  • 3车国卫,周清华.肺癌心脏转移瘤的临床诊治现状[J].中国肿瘤临床,2006,33(12):716-718. 被引量:14
  • 4社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3110
  • 5谢惠安 阳国太 林善梓 等.现代结核病学第1版[M].北京:人民卫生出版社,2002.421-2.
  • 6中国疾控中心结核病预防控制中心.结核病病例管理指导手册[M].2006:1.
  • 7Price NM,Gilman R H,Uddin J,et,al.Unopposed matrix metalloproteinase-9 in human tuberculous granuloma and the rale of TNF-alpha-dependent monocyte networks[J].The Journal of Immunology,2003,171(10):5579-5586
  • 8Quiding J K,Smith D A,Bancroft G J.Production of matrix metalloproteinases in response to mycobactrial infection[J].Infect immune,2001,69(9):5661-5669
  • 9Hayes A J,Mostyn-Jones A,Koban MU,et,al.Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma[J].Br J Surg,2004,91(2):242-247
  • 10Jin H Y,Lee K S,Jin S M et al.Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion[J].Respiratory Medicine,2004,98(2):115-122

共引文献3022

同被引文献264

引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部